Relipulse Pharmaceuticals Private Limited
About Relipulse Pharmaceuticals Private Limited
Data last updated:
Relipulse Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 10 August 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TS2023PTC175918.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rekha Devi Upadhyay and Komal Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.44 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹72.6 Lakh (net margin 13.4%) and EBITDA of ₹84.1 Lakh (EBITDA margin 15.5%).
As per MCA filings, the company has open charges of ₹1.1 Cr on record.
Company details
Contact details
Relipulse Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressD No 3 – 5 – 592 2nd Floor, Sunder Sadan, Hyderabad, Telangana, India – 500029
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Relipulse Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Relipulse Pharmaceuticals Private Limited, buy the company report.
Financials of Relipulse Pharmaceuticals Private Limited
FY 2025 filings availableRelipulse Pharmaceuticals Private Limited reported revenue of ₹5.44 Cr (up 1204% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹84.1 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹72.6 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 15.5% | |
| Net Profit Margin | 13.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Relipulse Pharmaceuticals Private Limited, buy the company report.
Board of directors of Relipulse Pharmaceuticals Private Limited
Relipulse Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Devi Upadhyay | Director | 10 Aug 2023 | 3 Years 2 Months | Current |
| Komal Upadhyay | Director | 10 Aug 2023 | 3 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2025 | 101207759 | Hdfc Bank Limited | ₹1.1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Relipulse Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relipulse Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Relipulse Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Relipulse Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Komal Upadhyay was appointed as Director on 10 Aug 2023.
Frequently asked questions
Relipulse Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 10 August 2023 (3+ years old) and is registered under CIN U21001TS2023PTC175918.
Relipulse Pharmaceuticals has 2 current directors:
- Rekha Devi Upadhyay - Director
- Komal Upadhyay - Director
The latest financial statements of Relipulse Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Relipulse Pharmaceuticals is U21001TS2023PTC175918. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relipulse Pharmaceuticals was incorporated on 10 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Komal Upadhyay was appointed as Director on 10 Aug 2023. Rekha Devi Upadhyay was appointed as Director on 10 Aug 2023.
The registered office of Relipulse Pharmaceuticals is at D No 3 – 5 – 592 2nd Floor, Sunder Sadan, Hyderabad, Telangana, India – 500029.
Relipulse Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Relipulse Pharmaceuticals has open charges of ₹1.1 Cr and no satisfied charges on record as per latest MCA filings.
Relipulse Pharmaceuticals can be reached at its registered office: D No 3 – 5 – 592 2nd Floor, Sunder Sadan, Hyderabad, Telangana, India – 500029.